REQUEST A DEMO
Total
USD $0.00
Search more companies

PT Simex Pharmaceutical Indonesia (Indonesia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: PT Simex Pharmaceutical Indonesia Profile Updated: February 23, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

pt. simex pharmaceuticals indonesia is a pharmaceutical company that offers a wide range of pharmaceutical products for all age groups and aims to become a reputable corporation in the pharmaceutical industry. They are equipped with professional manpower and modern technology instrumentation to produce high-quality drugs certified by the BPOM Indonesia.

Headquarters
Komplek Mitra Bahari 2, Blok E No. 15 - 16
North Jakarta; Jakarta; Postal Code: 14440

Contact Details: Purchase the PT Simex Pharmaceutical Indonesia report to view the information.

Website: http://www.simex.co.id

Basic Information
Total Employees:
Purchase the PT Simex Pharmaceutical Indonesia report to view the information.
Outstanding Shares:
Purchase the PT Simex Pharmaceutical Indonesia report to view the information.
Registered Capital:
Purchase the PT Simex Pharmaceutical Indonesia report to view the information.
Incorporation Date:
December 08, 2000
Key Executives
Purchase this report to view the information.
President Director
Purchase this report to view the information.
President Commissioner
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after PT Simex Pharmaceutical Indonesia report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
2.51%
Total operating revenue
2.51%
Total assets
1.59%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?